Cart
sales@molnova.com
Iberdomide
CAS No. 1323403-33-3
Iberdomide( CC-220 )
Catalog No. M21067 CAS No. 1323403-33-3
Iberdomide is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 155 | Get Quote |
|
| 25MG | 309 | Get Quote |
|
| 50MG | 551 | Get Quote |
|
| 100MG | 869 | Get Quote |
|
| 200MG | 1161 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIberdomide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIberdomide is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
-
DescriptionIberdomide is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
-
In Vitro——
-
In Vivo——
-
SynonymsCC-220
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number1323403-33-3
-
Formula Weight449.5
-
Molecular FormulaC25H27N3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (66.74 mM)
-
SMILESO=C1CCC(N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1
-
Chemical Name(S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-26-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matyskiela M E Zhang W Man H W et al. A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos[J]. Journal of Medicinal Chemistry 2017:acs.jmedchem.6b01921.
molnova catalog
related products
-
SD-36
SD-36 is a selective and efficient STAT3 protein degrader (Kd=~50 nM) with antitumor activity that promotes growth inhibition and induces apoptosis by inhibiting Mcl-1 in gliomas.SD-36 inhibits the transcriptional activity of STAT3.
-
Pyrazoloacridine
Pyrazoloacridine is a nucleic acid binding agent that inhibits the activity of topo I and II with an IC50 of 1.25 μM in K562 cells. Pyrazoloacridine shows anti-cancer activity.
-
TMI-1
TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
